Agreement marks first partnership of its kind between a research institution and reagents company; third major deal in TSRI's new partnering strategy TSRI approached Sigma-Aldrich to eliminate the ...

Sigma-Aldrich and Scripps Research Institute California are joining forces to provide “day of publication” access to Scripps-discovered reagents that have utility in drug discovery. The two ...

Sigma-Aldrich will fund research and development of new reagents by six researchers at the Scripps Research Institute (TSRI), in return for receiving immediate, day-of-publication access to their ...

Applications include cell lines with enhanced protein production performance and stem cell and transgenic animal models. Sigma-Aldrich and Sangamo BioSciences formed an alliance focused on the ...

Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading Life Science and Technology company, announced today it signed an exclusive global distribution agreement with Roche (SIX: RO, ROG; OTCQX: RHHBY).

The alliance combines Sigma's global marketing capabilities and with Sangamo's substantial expertise in the field of ZFPs. ZFPs are the dominant class of naturally occurring proteins known as ...

Roche ($RHHBY) inked an exclusive global deal with Sigma-Aldrich ($SIAL) to market and distribute its biochemical reagents portfolio. Under the terms of the deal ...

Six high-profile laboratories at The Scripps Research Institute have entered an alliance with Sigma-Aldrich that is the first of its kind for a chemical reagent supplier. Under the agreement announced ...

Merck KGaA may have struggled getting new drug products to market, but its $17 billion buyout of Sigma-Aldrich ($SIAL) will allow it to help others, as well as itself ...

Merck to acquire Sigma-Aldrich for $140 per share in cash, valuing company at approx. $17 billion (€13.1 billion) Acquisition expands Merck Millipore’s global reach, increasing the company’s presence ...